Internal Medicine, Endocrinology, Diabetes, & Metabolism · Orlando, FL
NPI
1104911452
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9166 University Blvd
Orlando, FL, 32817
Phone (407) 673-4600
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
749 services
Medicare patients, 2024
279
Average age 74
Drug cost, 2024
$1.3M
3,155 prescriptions
Company payments, 2025
$1,599
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rita Y Rahbany was code 99214 (office e&m - established), 309 times for 205 patients. In total Rita Y Rahbany billed 749 services in 7 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 309 | 205 | $78.68 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 257 | 194 | $12.33 | $3,169 |
| 99215 Office E&M - Established | Office | 135 | 97 | $125.45 | $17K |
| 99213 Office E&M - Established | Office | 27 | 27 | $36.55 | $987 |
| 99204 Office E&M - New | Office | 19 | 19 | $104.48 | $1,985 |
By year: 2022 $77K for 854 services; 2023 $84K for 924 services; 2024 $48K for 749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rita Y Rahbany prescribed most often to Medicare patients was Levothyroxine Sodium, with 333 prescriptions and refills. In total Rita Y Rahbany wrote 3,155 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 333 | 925 | 108 | $3,829 |
| Metformin Hcl Generic | 297 | 848 | 101 | $2,423 |
| Unithroid Levothyroxine Sodium | 171 | 460 | 54 | $11K |
| Trulicity Dulaglutide | 170 | 237 | 39 | $216K |
| Glimepiride Generic | 150 | 410 | 50 | $1,987 |
| Jardiance Empagliflozin | 146 | 349 | 43 | $202K |
| Farxiga Dapagliflozin Propanediol | 110 | 195 | 22 | $102K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 108 | 255 | 35 | $17K |
| Synthroid Levothyroxine Sodium | 107 | 260 | 28 | $9,744 |
| Rosuvastatin Calcium Generic | 106 | 313 | 40 | $1,566 |
| Metformin Hcl Er Metformin Hcl | 103 | 294 | 31 | $1,424 |
| Mounjaro Tirzepatide | 98 | 139 | 23 | $144K |
| Humalog Kwikpen U-100 Insulin Lispro | 68 | 145 | 19 | $16K |
| Tresiba Flextouch U-100 Insulin Degludec | 67 | 144 | 21 | $52K |
| Liothyronine Sodium Generic | 62 | 181 | 22 | $2,657 |
Brand drugs: 1,843 claims; generic drugs: 1,083 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rita Y Rahbany $1,599 ($1,599 in general payments such as food, travel and fees) from 18 companies. The largest payer was Insulet Corporation with $524.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 30 | $524 |
| Amgen Inc. AMGN | 6 | $218 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $166 |
| Novo Nordisk Inc NVO | 5 | $109 |
| Xeris Pharmaceuticals, Inc. | 5 | $101 |
| Lilly USA, LLC LLY | 3 | $89.45 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $63.65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58.13 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $52.89 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $37.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.